Drug Profile


Alternative Names: FTS-Zn; Nonathymulin; Thymalin; Thymic factor circulating; ZnFTS

Latest Information Update: 29 May 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nonindustrial source; Santen Pharmaceutical
  • Class Oligopeptides; Thymus hormones
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Ischaemic heart disorders; Rheumatoid arthritis

Most Recent Events

  • 18 May 2004 Suspended - Preclinical for Rheumatoid arthritis in Japan (unspecified route)
  • 31 Dec 1999 No-Development-Reported for Rheumatoid arthritis in Japan (Unknown route)
  • 31 Dec 1995 No-Development-Reported for Ischaemic heart disorders in Russia (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top